Finn Patrick John, President and COO of Twist Bioscience (TWST), has demonstrated a consistent pattern of selling company shares over the past year, with no recent purchases recorded in SEC filings. Since October 2025, John has executed 16 sales totaling approximately $6.94 million, with the largest transactions clustered in February 2026. Notably, on February 17, 2026, he sold shares worth $1.42 million, $854,444, and $1.1 million in separate transactions, alongside smaller dispositions earlier that month. These sales followed a $931,160 transaction on January 13, 2026, and multiple six-figure disposals in late 2025, including a $553,608 sale on October 30 and a $764,344 transaction on October 6.
John’s trading activity shows a clear divestment trend, with all 29 recorded transactions involving TWST stock. While he has acquired shares through awards (marked as "M" and "A" in filings), his outright purchases total just $1.41 million—far outweighed by sales. The absence of recent buys and the concentration of high-value sales in early 2026 suggest a continued reduction in his position. The transactions, ranging from small dispositions like a $6,007 sale on October 2, 2025, to seven-figure exits, reflect a methodical unwinding of holdings rather than isolated liquidity events.
AI-assisted summary